A preprint, not yet peer-reviewed, CITF-funded study found that only 45% of kidney transplant recipients (KTRs) developed Omicron-specific neutralizing antibodies one month following a third vaccine dose.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
